Avid Bioservices Inc (CDMO)

[biopharm]

Scott Antonia : Peregrine Pharmaceuticals KOL

I guess Scott Antonia could have been listed as Moffitt and Nilo Onco Oncosystems ...

----------------------------------------------------------
Nilo Oncosystems:

Our Team-

Sigrid M. Volko, Ph.D., CLP, President and Interim CEO, holds a Ph.D. in Biology from the University of Basel in Switzerland and worked as a Research Fellow at the Harvard Medical School in Boston. Dr. Volko is an experienced business development professional and a Certified Licensing Professional with more than 14 years experience in technology transfer at Massachusetts General Hospital in Boston and the Johns Hopkins University in Baltimore.

Soner Altiok, M.D., Ph.D., Founder and Chief Scientific Officer, is currently a Professor of Pathology and Oncological Sciences at the Moffitt Cancer Center and the University of South Florida in Tampa. Dr. Altiok holds an M.D. degree from the Medical School of Istanbul in Turkey and a Ph.D. degree in Molecular Cell Biology from the University of Basel in Switzerland. He completed his postdoctoral training in Boston, Massachusetts, at the Dana Farber Cancer Institute and the Beth Israel Deaconess Medical Center and pursued his clinical training in Pathology and Cytopathology at Massachusetts General Hospital, Harvard Medical School, in Boston. After his training Dr. Altiok became an Assistant Professor at the Johns Hopkins School of Medicine to continue his clinical and translational research efforts and joined the Moffitt Cancer Center in 2007. As a physician scientist he has expertise in diagnostic pathology, tissue procurement and processing as well as designing biomarker-driven clinical trials.

Scott Antonia, M.D., Ph.D., Chief Medical Officer, Dr. Antonia is currently the department chair and program leader of Thoracic Oncology and program leader of the Immunology Program at Moffitt Cancer Center. He is a Professor of Oncology at the University of South Florida College of Medicine. Dr. Antonia received both his medical degree and a doctorate in immunology from the University of Connecticut Health Center. He completed his internal medicine residency, medical oncology fellowship and post- doctoral training at Yale University School of Medicine. Dr. Antonia also serves as Medical Director of the Tumor Vaccine Production Facility at the Moffitt Cancer Center. He was named the Moffitt Physician of the Year in 2005 and Mentor of the Year in 2008.

http://www.inova.marketing/the-team.html

---------------------------------------------------------------

Author Block: Soner Altiok 1, Melanie Mediavilla-Valera 2, Jenny Kreahling2, David Noyes 2, Tiffany N. Razabdouski2, Nikoletta L. Kallinteris 3, Joseph Shan 3, Scott Antonia 2.

1Nilogen Oncosystems, Tampa, FL;
2Moffitt Cancer Center, Tampa, FL;
3Peregrine Pharmaceuticals, Inc, Tustin, CA

http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=3682&sKey=c0f97126-ef0e-4d5f-875e-5fb8501051b6&cKey=cba79523-81ca-46d6-b881-4a6e061e82ee&mKey=19573a54-ae8f-4e00-9c23-bd6d62268424

----------------------------------------------------------


EX VIVO MICROFLUIDIC ANALYSIS OF BIOLOGIC SAMPLES
Application number: 20140127733
Abstract: Systems and methods for culturing and monitoring, ex vivo, pharmacologic and metabolic response in a biological sample, including receiving at a fluidic apparatus the biological sample retrieved from the patient, retaining the biological sample within a channel of the fluidic apparatus, providing for the culture of the biological sample within the channel of the fluidic apparatus, flowing a fluid past the biological sample, retrieving and analyzing the fluid to determine a pharmacologic and/or metabolic response of the sample.
Type: Application
Filed: November 1, 2013
Issued: May 8, 2014
Assignees: Moffit Cancer Center, The Charles Stark Draper Laboratory, Inc.
Inventors: Soner Altiok, Alla Epshteyn, Angela Holton, David Landis, Abagail Spencer

https://patents.justia.com/inventor/soner-altiok

-------------------------------------------------------------

"As a cytopathologist, my focus is on applling techniques of cell biology and proteomics to the field of cytopathology to identify novel diagnostic and prognostic biomarkers."

http://moffitt.org/research--clinical-trials/individual-researchers/soner-altiok-md-phd

https://www.linkedin.com/pub/soner-altiok/34/36/126

---------------------------------------------------------------

Ties to Turkey now makes sense to many of the Turkish related followers of Peregrine Pharmaceuticals...

http://www.bioflorida.com/members/?id=31018458

http://www.bioflorida.com/?page=50

http://www.bioflorida.com/?page=50#jamesmule

...... notice James Mule on the BOD of BioFlorida and James Mule also associated with Scott Antonia on some cancer immunotherapy patents:

https://www.collectiveip.com/technology-transfer/h-lee-moffitt-cancer-center-and-research-institute/patents?fin=James+J.+Mule